Esperion Preps Nexletol/Nexlizet To Be ‘Clear Next Step’ After Statins

Outcomes Data Presented At ACC

 
• By Jessica Merrill
  
magnifying glass
CV outcomes data provides more clarity on Esperion's Nexletol • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapy Areas